Successful Treatment with Bosentan for Pulmonary Hypertension and Reduced Peripheral Circulation in...
Successful Treatment with Bosentan for Pulmonary Hypertension and Reduced Peripheral Circulation in Juvenile Systemic Sclerosis
About this item
Full title
Author / Creator
Publisher
New York: Springer-Verlag
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer-Verlag
Subjects
More information
Scope and Contents
Contents
Pulmonary arterial hypertension (PAH) when associated with systemic sclerosis (SSc) (SSc–PAH) is one of the leading causes of mortality and is found in 10–15% of adult patients with SSc. The ET receptor antagonist bosentan has been shown to be effective in the treatment of adult patients with SSc-PAH. Furthermore, it has been shown that bosentan am...
Alternative Titles
Full title
Successful Treatment with Bosentan for Pulmonary Hypertension and Reduced Peripheral Circulation in Juvenile Systemic Sclerosis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A715523779
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A715523779
Other Identifiers
ISSN
0172-0643
E-ISSN
1432-1971
DOI
10.1007/s00246-011-0056-z
